• Citer

Subjective cognitive complaints one year after ceasing adjuvant endocrine treatment for early-stage breast cancer.

par Ribi, K;Aldridge, Julie R.;Phillips, K-A;Thompson, A;Harvey, Vernon;Thürlimann, Beat;Cardoso, Fatima ;Pagani, Olivia;Coates, Alan;Goldhirsch, Aron;Price, Karen N.;Gelber, R D;Bernhard, Jürg;BIG 1-98 Collaborative and International Breast Cancer Study Groups, ;International Breast Cancer Study Group,
Référence British Journal of Cancer, 106, 10, page (1618-1625)
Publication Publié, 2012-05

Article révisé par les pairs

• Accès en ligne
• Détails
• Contenu
• Statistiques

Titre:	Subjective cognitive complaints one year after ceasing adjuvant endocrine treatment for early-stage breast cancer.
Auteur:	Ribi, K; Aldridge, Julie R.; Phillips, K-A; Thompson, A; Harvey, Vernon; Thürlimann, Beat; Cardoso, Fatima; Pagani, Olivia; Coates, Alan; Goldhirsch, Aron; Price, Karen N.; Gelber, R D; Bernhard, Jürg; BIG 1-98 Collaborative and International Breast Cancer Study Groups, ; International Breast Cancer Study Group,
Informations sur la publication:	British Journal of Cancer, 106, 10, page (1618-1625)
Statut de publication:	Publié, 2012-05
Sujet CREF:	Cancérologie
Mots-clés:	Aromatase inhibitor
	Breast cancer
	Letrozole
	Quality of life
	Subjective cognitive function
	Tamoxifen
MeSH keywords:	Aromatase Inhibitors -- adverse effects
	Breast Neoplasms -- drug therapy -- pathology -- psychology
	Cognition -- drug effects
	Estrogen Antagonists -- adverse effects
	Female
	Humans
	Neoplasm Staging
	Nitriles -- adverse effects
	Quality of Life
	Tamoxifen -- adverse effects
	Triazoles -- adverse effects
Note générale:	Journal Article
	Randomized Controlled Trial
	Research Support, N.I.H., Extramural
	Research Support, Non-U.S. Gov't
	SCOPUS: ar.j
Langue:	Anglais
Identificateurs:	urn:issn:0007-0920
	info:doi/10.1038/bjc.2012.156
	info:pii/bjc2012156
	info:scp/84860779907
	info:pmid/22531635
	PMC3349183